Orogenital ulcers in a liver transplant recipient: Discerning between mycophenolate-mofetil-induced complication and Behcet's disease

Clinical Transplantation

Volumn 23, Issue 2, 2009, Pages 147-149

  Savas, N ^a   Sevmis, S ^a   Karakayali, H ^a   Yilmaz, U ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; BEHCET DISEASE; BIOPSY; CASE REPORT; CLINICAL FEATURE; DIARRHEA; DISEASE DURATION; DRUG MEGADOSE; DRUG WITHDRAWAL; GENITAL ULCER; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HYPERPLASIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOW DRUG DOSE; LOWER LIP; MALE; MOUTH PAIN; MOUTH ULCER; ODYNOPHAGIA; PARENTERAL NUTRITION; PRIORITY JOURNAL; SCROTUM DISORDER; TONGUE ULCER;

BEHCET SYNDROME; GENITAL DISEASES, MALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; ORAL ULCER; PREDNISOLONE; ULCER;

EID: 64349102738     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00930.x     Document Type: Article

References (10)

1. Apostolou T, Tsagalis G, Koutroubas G, Hadjiconstantinou V, Drakopoulos S. Mycophenolate mofetil and oral ulcerations. Transplantation 2004: 77: 1911.
2. Garrigue V, Canet S, Dereure O et.al. Oral ulcerations in a renal transplant recipient: A mycophenolate mofetil-induced complication? Transplantation 2001: 72: 968.
3. Branger B, Zabadani B, Vecina F et al. Tunneled jugular catheters in chronic hemodialysis: Report from a Center apropos of 101 cases [in French]. Nephrologie 1994: 15: 73.
4. van Gelder T, ter Meulen CG, HenéR, Weimar W, Hoitsma A. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil. Transplantation 2003: 75: 788.
5. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1996: 61: 1029.
6. Smak Gregoor PJ, van Gelder T, Hesse CJ, van der Mast BJ, van Besouw NM, Weimar W. Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: A cross-sectional study. Nephrol Dial Transplant 1999: 14: 706.
7. Smak Gregoor PJ, de Sévaux RG, Ligtenberg G et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: A randomized, prospective, multicenter study. J Am Soc Nephrol 2002: 13: 1365.
8. Van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit 2001: 23: 119.
9. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990: 335: 1078.
10. Russell AI, Lawson WA, Haskard DO. Potential new therapeutic options in Behçet's syndrome. BioDrugs 2001: 15: 25.